Sun, Y.;                     Geng, X.;                     Ma, Y.;                     Qin, Y.;                     Hu, S.;                     Xie, Y.;                     Wang, R.    
        Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery. Pharmaceutics 2022, 14, 2781.
    https://doi.org/10.3390/pharmaceutics14122781
    AMA Style
    
                                Sun Y,                                 Geng X,                                 Ma Y,                                 Qin Y,                                 Hu S,                                 Xie Y,                                 Wang R.        
                Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery. Pharmaceutics. 2022; 14(12):2781.
        https://doi.org/10.3390/pharmaceutics14122781
    
    Chicago/Turabian Style
    
                                Sun, Yang,                                 Xinyao Geng,                                 Yue Ma,                                 Yu Qin,                                 Shangjiu Hu,                                 Yuquan Xie,                                 and Ruowen Wang.        
                2022. "Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery" Pharmaceutics 14, no. 12: 2781.
        https://doi.org/10.3390/pharmaceutics14122781
    
    APA Style
    
                                Sun, Y.,                                 Geng, X.,                                 Ma, Y.,                                 Qin, Y.,                                 Hu, S.,                                 Xie, Y.,                                 & Wang, R.        
        
        (2022). Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery. Pharmaceutics, 14(12), 2781.
        https://doi.org/10.3390/pharmaceutics14122781